Helmy Eltoukhy

Chief Executive Officer, Guardant Health

BSc, MSc and PhD in Electrical Engineering, Stanford. Serial entrepreneur and pioneer in the biotech industry. 2006, joined Stanford Genome Technology Center (SGTC); worked on low-cost DNA sequencing technologies; developed the first semiconductor sequencing platform and first base-calling algorithm for next-gen sequencing. 2007, Co-Founder and Founding CEO, Avantome (acquired by Illumina in 2008), founded to commercialize a low-cost, high-performance next-gen sequencing platform to seed the democratization of next-gen sequencing. Senior Director, Advanced Technology Research, Illumina; developed novel chemistries, hardware and informatics for genetic analysis systems.

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum